Aliases & Classifications for Respiratory System Disease

MalaCards integrated aliases for Respiratory System Disease:

Name: Respiratory System Disease 12 15
Abnormality of the Respiratory System 29 6
Respiratory Tract Diseases 73
Respiration Disorders 73

Classifications:



External Ids:

Disease Ontology 12 DOID:1579
ICD10 33 J96-J99 J98 10
ICD9CM 35 510-519.99 519

Summaries for Respiratory System Disease

Disease Ontology : 12 A disease of anatomical entity that located in the respiratory system which extends from the nasal sinuses to the diaphragm.

MalaCards based summary : Respiratory System Disease, also known as abnormality of the respiratory system, is related to upper respiratory tract disease and helicobacter pylori infection, and has symptoms including anoxemia, apnea and pleuritic pain. An important gene associated with Respiratory System Disease is TLR9 (Toll Like Receptor 9), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Methylprednisolone and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include the respiratory system which extends from the nasal sinuses to the diaphragm, lung and testes, and related phenotypes are hematopoietic system and homeostasis/metabolism

Related Diseases for Respiratory System Disease

Diseases related to Respiratory System Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 388)
# Related Disease Score Top Affiliating Genes
1 upper respiratory tract disease 31.3 CCL11 CD79A CXCL8 IL10 IL13 IL4
2 helicobacter pylori infection 31.0 CXCL8 IL10 IL1B TNF
3 paragonimiasis 11.3 IL13 IL5 RNASE3
4 intrinsic asthma 11.3 IL4 IL5 RNASE3
5 scleritis 11.3 IL4 IL5 TNF
6 atopic keratoconjunctivitis 11.3 IL4 IL5 RNASE3
7 blepharoconjunctivitis 11.3 CCL11 IL4 RNASE3
8 intestinal schistosomiasis 11.3 IL13 IL4 IL5
9 tropical endomyocardial fibrosis 11.3 IL10 IL4 TNF
10 chronic tic disorder 11.3 IL13 IL4 IL5
11 streptococcal toxic-shock syndrome 11.3 CXCL8 IL6 TNF
12 status asthmaticus 11.3 CXCL8 IL5 RNASE3
13 cytokine deficiency 11.3 IL13 IL5
14 recurrent corneal erosion 11.3 CXCL8 IL1B IL6
15 chronic meningitis 11.3 CCL11 CRP IL5
16 eye lymphoma 11.3 IL10 IL6 TLR9
17 endomyocardial fibrosis 11.3 IL10 IL4 TNF
18 cercarial dermatitis 11.3 IL1B IL4 IL5
19 burning mouth syndrome 11.3 IL6 TNF TRPV1
20 cough variant asthma 11.3 IL4 IL5 RNASE3 TRPV1
21 folliculitis 11.3 CCL11 IL4 IL5
22 actinic prurigo 11.2 IL13 IL1B TNF
23 mucocutaneous leishmaniasis 11.2 IL10 TLR9 TNF
24 necatoriasis 11.2 CXCL8 IL10 IL5
25 opisthorchiasis 11.2 CXCL8 IL1B IL4
26 inflammatory bowel disease 4 11.2 IL13 IL4 IL5 RNASE3
27 beta-lactam allergy 11.2 IL10 IL13 IL4
28 haemophilus influenzae 11.2 CXCL8 IL1B TNF
29 viral pneumonia 11.2 CRP IL6 TLR9
30 punctate inner choroidopathy 11.2 IL10 TNF
31 latex allergy 11.2 IL13 IL4 IL5 RNASE3
32 laryngitis 11.2 IL1B IL6 TNF
33 sinusitis 11.2 CXCL8 IL5 RNASE3
34 urinary schistosomiasis 11.2 IL13 IL4 IL5 RNASE3
35 meconium aspiration syndrome 11.2 CXCL8 IL6 TNF
36 crohn's colitis 11.2 CXCL8 IL1B TNF
37 acute transverse myelitis 11.2 CXCL8 IL10 IL6
38 angiostrongyliasis 11.2 CCL11 IL13 IL4 IL5
39 scabies 11.2 CCL11 CXCL8 IL10
40 esophageal disease 11.2 IL13 IL5 TRPV1
41 angioimmunoblastic lymphadenopathy with dysproteinemia 11.2 IL13 IL5 IL6 TNF
42 acute vascular insufficiency of intestine 11.2 IL1B IL6 TNF
43 eosinophilic meningitis 11.2 CCL11 IL13 IL4 IL5
44 burns 11.2 ALB IL1B TNF
45 enterobiasis 11.2 IL13 IL4 IL5
46 poems syndrome 11.2 IL1B IL6 TNF
47 pyuria 11.2 ALB CRP CXCL8
48 eosinophilic gastritis 11.2 CCL11 IL13 IL4 IL5
49 vulvovaginitis 11.2 CCL11 CXCL8 IL10
50 scorpion envenomation 11.2 IL6 TNF

Comorbidity relations with Respiratory System Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Bronchitis
Heart Disease Hypertension, Essential
Ischemic Heart Disease Respiratory Failure

Graphical network of the top 20 diseases related to Respiratory System Disease:



Diseases related to Respiratory System Disease

Symptoms & Phenotypes for Respiratory System Disease

UMLS symptoms related to Respiratory System Disease:


anoxemia, apnea, pleuritic pain, cheyne-stokes respiration, coughing, cyanosis, dyspnea, edema, hemoptysis, hoarseness, stridor, wheezing, sinus congestion, other symptoms involving respiratory system and chest, signs and symptoms of ill-defined conditions, inspiratory wheeze, expiratory wheeze, bronchorrhea, neonatal cyanosis, gasping for breath, symptoms involving respiratory system and other chest symptoms, respiratory distress, choking sensation, labored breathing, inspiratory stridor, nasal congestion (finding), pathological conditions, signs and symptoms, nasal irritation, sore throat, neck tightness, larynx pain, rhinorrhea

MGI Mouse Phenotypes related to Respiratory System Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.22 TNF AREG CCL11 CD79A IL10 IL13
2 homeostasis/metabolism MP:0005376 10.21 TLR9 TNF TRPV1 ALB AREG CD79A
3 immune system MP:0005387 10.2 AREG CCL11 CD79A CRP IL10 IL13
4 digestive/alimentary MP:0005381 10.09 ALB AREG IL10 IL13 IL4 IL5
5 integument MP:0010771 9.86 IL10 IL13 IL1B IL4 IL6 TNF
6 liver/biliary system MP:0005370 9.76 ALB CD79A IL10 IL4 IL5 IL6
7 neoplasm MP:0002006 9.56 ALB CD79A IL10 IL1B IL5 IL6
8 respiratory system MP:0005388 9.23 CCL11 IL10 IL13 IL4 IL5 IL6

Drugs & Therapeutics for Respiratory System Disease

Drugs for Respiratory System Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1197)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 83-43-2 6741
2
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-24-8 5755
3
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
4
Caspofungin Approved Phase 4,Phase 3 179463-17-3, 162808-62-0 468682 2826718
5
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
6
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
7
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 113775-47-6 68602 5311068
8
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
9
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-43-4 5816
10
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 329-65-7 838
11
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 83905-01-5 55185 447043
12
Cefuroxime Approved Phase 4,Phase 3,Phase 2,Not Applicable 55268-75-2 5361202 5479529
13
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 85721-33-1 2764
14
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81103-11-9 84029
15
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 354812-41-2, 151096-09-2 152946
16
Penicillin G Approved, Vet_approved Phase 4,Phase 3,Phase 1 61-33-6 5904
17
Piperacillin Approved Phase 4,Phase 2,Phase 3 66258-76-2 43672
18
Salmon Calcitonin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 47931-85-1 16129616
19
Tazobactam Approved Phase 4,Phase 2,Phase 3,Phase 1 89786-04-9 123630
20
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51333-22-3 63006 5281004
21
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 58-61-7 60961
22
Bambuterol Approved, Investigational Phase 4,Phase 1,Not Applicable 81732-65-2, 81732-46-9 54766
23
Terbutaline Approved Phase 4,Phase 3,Phase 1,Not Applicable 23031-25-6 5403
24
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 299-42-3 9294
25
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 93-14-1 3516
26
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90-82-4 7028
27
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 158966-92-8 5281040
28
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 90566-53-3 62924
29
Ipratropium Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22254-24-6, 60205-81-4 43232
30
Procaterol Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 72332-33-3 688561
31
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
32
Metoprolol Approved, Investigational Phase 4,Phase 3,Not Applicable 37350-58-6, 51384-51-1 4171
33
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Not Applicable 471-34-1
34
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 10102-43-9 145068 160954
35
Amikacin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 37517-28-5 37768
36
Sulbactam Approved Phase 4,Phase 3,Phase 2,Phase 1 68373-14-8
37
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 564-25-0 54671203
38
Tobramycin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 32986-56-4 5496 36294
39
Simvastatin Approved Phase 4,Phase 3,Phase 1,Phase 2 79902-63-9 54454
40
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 100986-85-4 149096
41
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 82419-36-1 4583
42
Linezolid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 165800-03-3 441401
43
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 64-17-5 702
44
Acetylcysteine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 616-91-1 12035
45
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-28-2 5757
46 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 979-32-8
47
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 57-63-6 5991
48
Metronidazole Approved Phase 4,Phase 3,Not Applicable 443-48-1 4173
49
Norgestimate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 35189-28-7 6540478
50
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 28014-46-2

Interventional clinical trials:

(show top 50) (show all 10004)
# Name Status NCT ID Phase Drugs
1 Exacerbation Prevention GOLD IV COPD With Non Invasive Mechanical Ventilation Unknown status NCT01481727 Phase 4
2 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4 Extra fine Formoterol/Beclomethasone
3 Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion Unknown status NCT01353105 Phase 4
4 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
5 Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis Unknown status NCT02464683 Phase 4
6 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Unknown status NCT01595750 Phase 4 Roflumilast 500;Placebo
7 Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease Unknown status NCT01499433 Phase 4 caspofungin
8 Cpap at Delivery Room for Preterm Infants Unknown status NCT01024361 Phase 4
9 Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical Anesthesia Unknown status NCT01703130 Phase 4
10 Placebo Controlled Evaluation of Sedation and Physiological Response to Intranasal Dexmedetomidine in Severe COPD Unknown status NCT02773797 Phase 4 IN-DEX 1.0 mcg/kg, intranasal saline;IN-DEX 1.5 mcg/kg, intranasal saline;Placebo - Saline
11 Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) Unknown status NCT01319643 Phase 4 Oxygen
12 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
13 Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections Unknown status NCT02171338 Phase 4
14 Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients Unknown status NCT02934945 Phase 4 budesonide 160μg/formoterol 4.5μg
15 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
16 Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics Unknown status NCT02574975 Phase 4 methacholine;adenosine monophosphate;leukotriene D4;budesonide /formoterol
17 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
18 Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD Unknown status NCT02197871 Phase 4
19 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
20 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4 Su-Huang antitussive capsule;Sugar pill
21 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Unknown status NCT01404013 Phase 4 ICS/LABA;Montelukast;ICS/LABA and Montelukast
22 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
23 The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD Unknown status NCT01243788 Phase 4 Salmeterol/Fluticasone Propionate
24 Description of the Ability to Learn How to Handle Inhaler Devices in COPD Unknown status NCT02813200 Phase 4 Seretide® Diskus® 500/550 μg;Ultibro® Breezhaler® 110/50 μg;Spiriva® Respimat® 2,5 μg
25 Secondhand Smoke Respiratory Health Study Unknown status NCT02797275 Phase 4 Albuterol;Placebo
26 Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease Unknown status NCT02563184 Phase 4
27 Pulmonary Gas Exchange Response to Indacaterol in COPD Unknown status NCT02547558 Phase 4 Indacaterol
28 A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection Unknown status NCT02539277 Phase 4 Jinyebaidu granule;Fufangshuanghua granule;Jinyebaidu granule placebo;Fufangshuanghua granule placebo
29 An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD Unknown status NCT02269800 Phase 4 Benzalkonium chloride solution;Normal saline
30 Strategy to Improve Adherence of Roflumilast Unknown status NCT02018432 Phase 4 Roflumilast escalation dosage;Roflumilast conventional dosage
31 Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT01721291 Phase 4 SALBUTAMOL
32 Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease Unknown status NCT01465906 Phase 4 tulobuterol;Tiotropium Bromide;tiotropium bromide
33 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4 fluticasone/ salmeterol 125/25 mcg/puff;fluticasone/ salmeterol 250/25 mcg/puff
34 The Role of Opinion Leaders in Enhancing Evidence-based Care After Chronic Obstructive Pulmonary Disease (COPD) Emergency Department (ED) Visits Unknown status NCT01107613 Phase 4
35 Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00288548 Phase 4 Metoprolol
36 Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial Unknown status NCT00120978 Phase 4 Advair;Flovent
37 Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis Unknown status NCT02169570 Phase 4
38 Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure Unknown status NCT01873521 Phase 4
39 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients Unknown status NCT01382368 Phase 4 Sildenafil
40 Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA Unknown status NCT02546349 Phase 4 fluticasone/salmeterol, tiotropium
41 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
42 Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis Unknown status NCT02509091 Phase 4 Bronchoalveolar Lavage and Local Amikacin Injection
43 Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02507843 Phase 4 Cholecalciferol;Placebo
44 FRC Guided Therapy in Acute Respiratory Failure Unknown status NCT01280019 Phase 4
45 Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection Unknown status NCT01897831 Phase 4 xin te mie
46 Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00857038 Phase 4 Doxycycline;Placebo
47 Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection Unknown status NCT01760109 Phase 4 Piperacillin Sodium and Sulbactam Sodium
48 EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema Unknown status NCT00730301 Phase 4
49 A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis Unknown status NCT01677403 Phase 4 Tobramycin;Saline
50 Simvastatin in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00680641 Phase 4 Simvastatin;Placebo

Search NIH Clinical Center for Respiratory System Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Genetic Tests for Respiratory System Disease

Genetic tests related to Respiratory System Disease:

# Genetic test Affiliating Genes
1 Abnormality of the Respiratory System 29

Anatomical Context for Respiratory System Disease

The Foundational Model of Anatomy Ontology organs/tissues related to Respiratory System Disease:

19
The Respiratory System Which Extends From The Nasal Sinuses To The Diaphragm

MalaCards organs/tissues related to Respiratory System Disease:

41
Lung, Testes, Heart, Endothelial, Liver, Brain, Bone

Publications for Respiratory System Disease

Articles related to Respiratory System Disease:

# Title Authors Year
1
Respiratory System Disease. ( 27469180 )
2016
2
Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. ( 16759841 )
2007
3
Alpha 1-antitrypsin gene polymorphism related to respiratory system disease. ( 2887693 )
1987
4
Death from respiratory system disease among Seventh-Day Adventist men. ( 5953042 )
1966

Variations for Respiratory System Disease

ClinVar genetic disease variations for Respiratory System Disease:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 46;XY;t(9;14)(p21;q12)dn Translocation Uncertain significance

Expression for Respiratory System Disease

Search GEO for disease gene expression data for Respiratory System Disease.

Pathways for Respiratory System Disease

Pathways related to Respiratory System Disease according to GeneCards Suite gene sharing:

(show top 50) (show all 59)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.1 CCL11 CD79A CRP CXCL8 IL10 IL13
2
Show member pathways
13.92 AREG CCL11 CCL15 CXCL8 IL10 IL13
3
Show member pathways
13.74 CCL11 CCL15 CXCL8 IL10 IL13 IL1B
4
Show member pathways
13.57 AREG CCL11 CCL15 CXCL8 IL10 IL13
5
Show member pathways
13.46 AREG CCL11 CCL15 CXCL8 IL10 IL13
6
Show member pathways
13.45 CCL11 CXCL8 IL10 IL13 IL1B IL4
7
Show member pathways
13.36 AREG CCL11 CCL15 CXCL8 IL10 IL13
8
Show member pathways
13.05 CXCL8 IL10 IL1B IL6 TLR9 TNF
9
Show member pathways
12.91 CCL11 CXCL8 IL10 IL13 IL1B IL4
10
Show member pathways
12.89 CXCL8 IL13 IL1B IL4 IL6 TLR9
11
Show member pathways
12.74 AREG IL1B IL6 TLR9 TNF
12
Show member pathways
12.72 CXCL8 IL10 IL13 IL1B IL4 IL5
13
Show member pathways
12.68 CD79A IL13 IL4 IL5 MS4A2 TNF
14 12.66 CD79A IL10 IL1B IL4 TLR9 TNF
15
Show member pathways
12.54 IL10 IL1B IL4 IL5 IL6 TNF
16
Show member pathways
12.54 IL10 IL13 IL1B IL4 IL5 IL6
17
Show member pathways
12.45 ALB CRP IL1B IL4 IL6 TNF
18
Show member pathways
12.36 IL10 IL1B IL6 TLR9 TNF
19
Show member pathways
12.35 CCL11 CXCL8 IL13 IL1B IL4 IL5
20 12.34 IL10 IL1B IL6 TLR9 TNF
21
Show member pathways
12.33 CXCL8 IL1B IL6 MUC5B TNF
22
Show member pathways
12.31 CXCL8 IL1B IL6 TNF
23
Show member pathways
12.31 IL10 IL1B IL6 TLR9 TNF
24
Show member pathways
12.3 CXCL8 IL6 TLR9 TNF
25
Show member pathways
12.29 IL10 IL1B IL4 TNF
26 12.29 CXCL8 IL10 IL13 IL1B IL6 TNF
27
Show member pathways
12.26 CCL11 CXCL8 IL1B IL4 IL6 TLR9
28 12.13 CXCL8 IL1B IL4 IL6 TNF
29
Show member pathways
12.12 AREG CCL11 CCL15 CXCL8 IL10 IL13
30 12.11 CD79A IL10 IL4 IL5 IL6 TNF
31
Show member pathways
12.1 IL13 IL1B IL5 TLR9
32 12.02 IL1B IL4 IL5 IL6 TNF
33 12.01 CXCL8 IL10 IL1B IL6 TNF
34 11.99 CXCL8 IL1B IL6 TNF
35 11.98 CCL11 CXCL8 IL10 IL13 IL1B IL4
36